Industry Says MDR Draft Guidance Would Lead To Redundant Reporting

Industry complained that provisions of FDA’s draft guidance on medical device reporting for manufacturers could lead to duplicative reporting and is unhappy with a requirement to formally request exemptions from MDR reporting.